Akanda Corp. (AKAN)
NASDAQ: AKAN · Real-Time Price · USD
1.250
+0.040 (3.31%)
May 28, 2025, 4:00 PM - Market closed
Company Description
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis-based products for medicinal use worldwide.
The company offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in Toronto, Canada.
Akanda Corp.
| Country | Canada |
| Founded | 2021 |
| IPO Date | Mar 15, 2022 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 46 |
| CEO | Katharyn Field |
Contact Details
Address: 100 King St. W, Suite 1600 Toronto, ON M5X 1G5 Canada | |
| Website | akandacorp.com |
Stock Details
| Ticker Symbol | AKAN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001888014 |
| CUSIP Number | 00971M106 |
| ISIN Number | CA00971M2058 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Katharyn Field | Interim Chief Executive Officer and Executive Director |
| Dr. Gurcharn Deol B.A., M.A., Ph.D. | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 1, 2025 | 6-K | Report of foreign issuer |
| Apr 30, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Apr 18, 2025 | 6-K | Report of foreign issuer |
| Apr 16, 2025 | 6-K | Report of foreign issuer |
| Apr 1, 2025 | 6-K | Report of foreign issuer |
| Mar 11, 2025 | 6-K | Report of foreign issuer |
| Nov 26, 2024 | 6-K | Report of foreign issuer |
| Nov 12, 2024 | 6-K | Report of foreign issuer |
| Oct 30, 2024 | 6-K | Report of foreign issuer |
| Oct 4, 2024 | 6-K | Report of foreign issuer |